articleThe LancetJun 7, 2024GREEN OA

Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial

PJPeter J. KellyRLRobin LemmensCWChristian WeimarCWCathal WalshFPFrancisco Purroy

Mater Misericordiae University Hospital · KU Leuven · +29 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

129
total citations
FWCI
28.02
Percentile
100%
References
29
Citations per year

Authors

32
  • PJ
    Peter J. KellyCorresponding

    Mater Misericordiae University Hospital

  • RL
    Robin Lemmens

    Mater Misericordiae University Hospital, KU Leuven

  • CW
    Christian Weimar

    Mater Misericordiae University Hospital, University of Duisburg-Essen

  • CW
    Cathal Walsh

    Trinity College Dublin, Mater Misericordiae University Hospital

  • FP
    Francisco Purroy

    Hospital Universitari Arnau de Vilanova, Mater Misericordiae University Hospital

Topics & keywords

Topics
Keywords
  • Medicine
  • Colchicine
  • Stroke (engine)
  • Term (time)
  • Randomized controlled trial
  • Intensive care medicine
  • Cardiology
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding